SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is seeing heightened volatility and investor debate following the company's private exchange of debt for equity, a move that reduces long-term debt but introduces dilution concerns. The community remains deeply polarized, with some bulls interpreting the balance sheet cleanup as a precursor to future acquisitions, while others express frustration over share count expansion and a lack of clear management guidance.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is surging as investor optimism builds following an analyst price target hike and the launch of a new clinical trial, fueling speculation about long-term growth and potential M&A activity. Community discussion is dominated by bullish sentiment regarding the company's Briumvi franchise, with many investors anticipating significant upside as the firm advances its pipeline into new indications like schizophrenia.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as investors gear up for the company's second-quarter earnings release, with discussions centering on the firm's rapid store expansion, improving profitability, and ongoing speculation regarding a potential move away from the OTC market. While some community members remain focused on store productivity and competitive pressures in the Chinese coffee landscape, many are bullish on the stock's long-term growth trajectory and recent digital initiatives.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors eagerly await top-line clinical data from the IZAR-1 trial, with community sentiment split between frustration over delayed timelines and bullish conviction in the company's inflammatory disease pipeline. While recent insider share sales and price consolidation have fueled skepticism and retail impatience, the active discussion remains centered on the potential for a transformative data readout to trigger a significant re-rating or M&A interest.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending after reporting a major earnings beat and a significant re-acceleration in AWS growth, which has renewed investor confidence in the company's ability to monetize massive AI infrastructure spending. Community sentiment is overwhelmingly bullish as the stock approaches record levels, with traders closely monitoring its ability to maintain momentum above key resistance zones.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is seeing significant market volatility as investors focus on a binary outcome surrounding its cancer therapy following an Advisory Committee meeting. Community sentiment is deeply polarized, with active debates centered on whether recent data signals efficacy or if the company faces a third complete response letter, leading to high levels of hedging and short-interest speculation.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics is experiencing heightened community interest and volatility as investors position themselves ahead of the upcoming Q2 earnings report. Discussions remain heavily polarized, with significant focus on the stock's high short interest and speculative squeeze potential versus concerns regarding operational cash burn and dilution.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.

Cardano

Cardano is drawing intense debate as the community remains divided between those viewing current price levels as a generational accumulation opportunity following recent volatility and those labeling the asset a declining project with fading relevance. While some investors point to upcoming legislative catalysts and protocol upgrades as potential drivers for a reversal, others are liquidating positions due to frustrations over extended price stagnation and persistent security concerns within the ecosystem.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solar is experiencing significant volatility driven by a mixed earnings report, where strong sales volume was offset by guidance that fell short of analyst expectations. Despite this pullback, the community remains actively divided between those highlighting the company's long-term manufacturing moat and domestic energy independence and those concerned about the impact of shifting tariff policies and competitive pressures.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is trending due to reports of potential merger discussions with AstraZeneca, alongside ongoing community interest in the company's efforts to revitalize its pharmaceutical pipeline and address patent cliffs. Investors are actively debating the viability of such large-scale consolidation and the potential for significant cost-cutting and portfolio optimization if a deal proceeds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's What Could Help Colony Bankcorp (CBAN) Maintain Its Recent Price Strength

If you are looking for stocks that are well positioned to maintain their recent uptrend, Colony Bankcorp (CBAN) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Colony Bankcorp (CBAN) Q2 Earnings and Revenues Top Estimates

Colony Bankcorp (CBAN) delivered earnings and revenue surprises of +8.33% and +3.08%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Colony Bankcorp, Inc. Reports Second Quarter 2026 Results

Colony Bankcorp, Inc. (NYSE: CBAN) (Colony or the Company) today reported financial results for the second quarter of 2026. Financial highlights are shown below. Financial Highlights: Net income increased to $10.9 million, or $0.51 per diluted share, for the second quarter of 2026, compared to $8.2...

Southern First (SFST) Q2 Earnings Surpass Estimates

Southern First (SFST) delivered earnings and revenue surprises of +0.84% and -0.78%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

What Makes Colony Bankcorp (CBAN) a Strong Momentum Stock: Buy Now?

Does Colony Bankcorp (CBAN) have what it takes to be a top stock pick for momentum investors? Let's find out.

Colony Bankcorp (CBAN) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colony Bankcorp (CBAN) have what it takes? Let's find out.

What Makes Colony Bankcorp (CBAN) a Good Fit for 'Trend Investing'

Colony Bankcorp (CBAN) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Customers Bancorp (CUBI) Earnings Expected to Grow: Should You Buy?

Customers Bancorp (CUBI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Colony Bankcorp (CBAN) Reports Next Week: Wall Street Expects Earnings Growth

Colony Bankcorp (CBAN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Colony Bankcorp, Inc. Announces Date for Second Quarter 2026 Earnings Release and Conference Call

Colony Bankcorp, Inc. (NYSE: CBAN) (Colony or the Company) today announced that it will release its second quarter 2026 financial results on Wednesday, July 22, 2026, after the stock market closes. The Company will also hold a live conference call on Thursday, July 23, 2026, at 9:00 AM ET.The...

$CBAN Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.51 up 10.87% YoY
• Reported revenue of $42.03M up 29.38% YoY

Colony Bankcorp, Inc. is a bank holding company, which engages in the stockholder and investor relations functions through its subsidiary, Colony Bank. It operates through the following segments: Banking Division, Mortgage Division, and Small Business Specialty Lending Division. The Banking Division segment offers full service financial services including commercial loans, consumer loans and deposit accounts. The Mortgage Division segment consists of sales and servicing of one-to-four family residential mortgage loans. The Small Business Specialty Lending Division segment focuses on the selling and servicing of SBA and USDA government guaranteed loans. The company was founded on November 8, 1982 and is headquartered in Fitzgerald, GA.

Colony Bankcorp, Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$21.97
Prev Close	$21.92
Open	$22.25
Dividend Yield	2.58%
50-Day Moving Average	$20.56
Beta	0.79
Avg. Volume	395,354.97
PE Ratio	13.27

52-Week High	$22.29
52-Week Low	$15.80
Market Capitalization	$463.79M
EPS (Annual)	$1.59
Price to Book	1.19
Revenue Per Employee	$361,659.70

Feed

News

Sentiment

Earnings

Fundamentals

Info